Advise Limiting NSAIDs in Patients With Cardiovascular Disease

We're still getting questions about NSAID safety.

NSAID labels have warned about CV and GI risks for years. And warnings have become stronger based on data gathered over the past decade.

For example, we know that NSAIDs slightly increase CV risk in patients with or without CV disease. We also know risk goes up within DAYS of use...and with higher NSAID doses and longer durations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote